Explore All Access
Check if your research matches the topics covered in Advances in Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Advances in Therapy : Impact Factor & More
eISSN: 1865-8652pISSN: 0741-238X
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Advances in Therapy is a monthly peer-reviewed medical journal covering clinical medicine, especially research on pharmaceuticals. The Managing Editor is Clare Shepherd. The journal publishes original clinical research papers and review articles. The journal was established in 1984 and published by Health Communications. Since 2008 it has been published by Springer Science+Business Media. Less
Advances in Therapy Key Metrics
CiteScore 
5
Eigenfactor
0.005 - 0.01
H-Index
74
Impact Factor
< 5
Scite Index
0.88 5-Year SI
SJR
Q1Pharmacology (medical)
SNIP
1.37
Time to Accept
2
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months48%
4 to 6 months47%
7 to 9 months4%
Above 9 months1%
Did you find this useful?
Topics Covered on Advances in Therapy
Cancer
Body mass index
Clinical trial
Randomized controlled trial
Rheumatoid arthritis
Renal function
Anemia
Type 2 diabetes
Atrial fibrillation
Psoriatic arthritis
Migraine
Blood pressure
Confidence interval
Glaucoma
Bupivacaine
Placebo
Epidermal growth factor receptor
Hepatocellular carcinoma
Overall survival
Multiple sclerosis
Advances in Therapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1984 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Advances in Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Advances in Therapy
Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry.
- 9 Dec 2024
- Advances in therapy
Machine Learning Applications in Acute Coronary Syndrome: Diagnosis, Outcomes and Management.
- 6 Dec 2024
- Advances in therapy
Adherence and Persistence with Single-Inhaler Triple Therapy Among Patients with COPD Using Commercial and Medicare Advantage US Health Plan Claims Data.
- 5 Dec 2024
- Advances in therapy
Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice.
- 5 Dec 2024
- Advances in therapy
Correction to: Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).
- 5 Dec 2024
- Advances in therapy
Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis.
- 5 Dec 2024
- Advances in therapy
Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry.
- 9 Dec 2024
- Advances in therapy
Machine Learning Applications in Acute Coronary Syndrome: Diagnosis, Outcomes and Management.
- 6 Dec 2024
- Advances in therapy
Adherence and Persistence with Single-Inhaler Triple Therapy Among Patients with COPD Using Commercial and Medicare Advantage US Health Plan Claims Data.
- 5 Dec 2024
- Advances in therapy
Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice.
- 5 Dec 2024
- Advances in therapy
Correction to: Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).
- 5 Dec 2024
- Advances in therapy
Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis.
- 5 Dec 2024
- Advances in therapy
Compare Similar Journals with Advances in Therapy
Select Journals to Compare with Advances in Therapy
Total journals - 9
You can select up to 3 Journals at a time
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Medicine
Publisher: Elsevier
BMJ Open
Publisher: BMJ PUBLISHING GROUP
Journal of Clinical Medicine
Publisher: MDPI
Value in Health
Publisher: ELSEVIER SCIENCE INC
Scientific Reports
Publisher: NATURE PORTFOLIO
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Nutrients
Publisher: MDPI
International Journal of Environmental Research and Public Health
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
0 Journals Selected to compare with
Advances in Therapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Advances in Therapy
How long has Advances in Therapy been actively publishing? 
Advances in Therapy has been in operation since 1984 till date.
What is the publishing frequency of Advances in Therapy?
Advances in Therapy published with a Monthly frequency.
How many articles did Advances in Therapy publish last year?
In 2023, Advances in Therapy publsihed 343 articles.
What is the eISSN & pISSN for Advances in Therapy?
For Advances in Therapy, eISSN is 1865-8652 and pISSN is 0741-238X.
What is Citescore for Advances in Therapy?
Citescore for Advances in Therapy is 5.
What is the H Index for Advances in Therapy ?
H Index for Advances in Therapy is 74.
What is SNIP score for Advances in Therapy?
SNIP score for Advances in Therapy is 1.37.
What is the SJR for Advances in Therapy?
SJR for Advances in Therapy is Q1.
Who is the publisher of Advances in Therapy?
SPRINGER is the publisher of Advances in Therapy.
